US 12208092
Compositions and methods for administering paltusotine to patients with hepatic impairment
granted A61KA61K31/381A61K31/4709
Quick answer
US patent 12208092 (Compositions and methods for administering paltusotine to patients with hepatic impairment) held by CRINETICS PHARMACEUTICALS, INC. expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRINETICS PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/381, A61K31/4709, A61K9/0053, A61K9/2013